Chlamydia-secreted proteins in chlamydial interactions with host cells

Current Chemical Biology

Volumn 5, Issue 1, 2011, Pages 29-37

  Zhong, Guangming ^a   Lei, Lei ^a   Gong, Siqi ^a   Lu, Chunxie ^a   Qi, Manli ^a   Chen, Ding ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Chlamydia; Effectors; Host pathogen interactions; Pathogenesis; Secretion

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOPROTEIN; TRANSLOCATED ACTIN RECRUITING PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; BACTERIAL GROWTH; BACTERIAL SECRETION SYSTEM; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; BIOINFORMATICS; CELL FRACTIONATION; CELL INCLUSION; CHLAMYDIA; CHLAMYDIASIS; CYTOPLASM; CYTOSOL; GOLGI COMPLEX; HOST CELL; HOST PATHOGEN INTERACTION; INFLAMMATION; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

CHLAMYDIA;

EID: 78951472578     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231311793564324     Document Type: Article

References (121)

1. Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999; 49 Pt 2: 415-40.
2. Read TD, Brunham RC, Shen C, et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 2000; 28: 1397-406.
3. Read TD, Myers GS, Brunham RC, et al. Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res 2003; 31: 2134-47.
4. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282: 754-9.
5. Carlson JH, Porcella SF, McClarty G, Caldwell HD. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun 2005; 73: 6407-18.
6. Clifton DR, Fields KA, Grieshaber SS, et al. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci USA 2004; 101: 10166-71.
7. Engel J. Tarp and Arp: How Chlamydia induces its own entry. Proc Natl Acad Sci USA 2004; 101: 9947-8.
8. Chen JC, Stephens RS. Chlamydia trachomatis glycosaminoglycandependent and independent attachment to eukaryotic cells. Microb Pathog 1997; 22: 23-30.
9. Su H, Caldwell HD. In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein. Infect Immun 1991; 59: 2843-5.
10. Swanson AF, Kuo CC. Evidence that the major outer membrane protein of Chlamydia trachomatis is glycosylated. Infect Immun 1991; 59: 2120-5.
11. Crane DD, Carlson JH, Fischer ER, et al. Chlamydia trachomatis polymorphic membrane protein D is a species-common panneutralizing antigen. Proc Natl Acad Sci USA 2006; 103: 1894-9.
12. Puolakkainen M, Kuo CC, Campbell LA. Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells. Infect Immun 2005; 73: 4620-5.
13. Guseva NV, Dessus-Babus SC, Whittimore JD, Moore CG, Wyrick PB. Characterization of estrogen-responsive epithelial cell lines and their infectivity by genital Chlamydia trachomatis. Microbes Infect 2005; 7: 1469-81.
14. Shimazaki K, Chan AM, Moniz RJ, et al. Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection model. FEMS Immunol Med Microbiol 2009; 55: 240-9.
15. Elwell CA, Ceesay A, Kim JH, Kalman D, Engel JN. RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog 2008; 4: e1000021.
16. Abromaitis S, Stephens RS. Attachment and entry of Chlamydia have distinct requirements for host protein disulfide isomerase. PLoS Pathog 2009; 5: e1000357.
17. Conant CG, Stephens RS. Chlamydia attachment to mammalian cells requires protein disulfide isomerase. Cell Microbiol 2007; 9: 222-32.
18. Davis CH, Raulston JE, Wyrick PB. Protein disulfide isomerase, a component of the estrogen receptor complex, is associated with Chlamydia trachomatis serovar E attached to human endometrial epithelial cells. Infect Immun 2002; 70: 3413-8.
19. Barbouche R, Miquelis R, Jones IM, Fenouillet E. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J Biol Chem 2003; 278: 3131-6.
20. Gallina A, Hanley TM, Mandel R, et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem 2002; 277: 50579-88.
21. Gowthaman U, Jayakanthan M, Sundar D. Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry. BMC Bioinformatics 2008; 9(Suppl 12): S14.
22. Papandreou MJ, Barbouche R, Guieu R, et al. Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase. J Biol Chem 2010; 285: 13788-96.
23. Dautry-Varsat A, Subtil A, Hackstadt T. Recent insights into the mechanisms of Chlamydia entry. Cell Microbiol 2005; 7: 1714-22.
24. Hower S, Wolf K, Fields KA. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 2009; 72: 1423-37.
25. Scidmore MA, Fischer ER, Hackstadt T. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect Immun 2003; 71: 973-84.
26. Wang J, Chen L, Chen F, et al. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine 2009; 27: 2967-80.
27. Jamison WP, Hackstadt T. Induction of type III secretion by cell-free Chlamydia trachomatis elementary bodies. Microb Pathog 2008; 45: 435-40.
28. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J 1996; 15: 964-77.
29. McClarty G. Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol 1994; 2: 157-64.
30. Zhong G, Fan P, Ji H, Dong F, Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 2001; 193: 935-42.
31. Rockey DD, Heinzen RA, Hackstadt T. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol Microbiol 1995; 15: 617-26.
32. Li Z, Chen C, Chen D, Wu Y, Zhong Y, Zhong G. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun 2008; 76: 2746-57.
33. Li Z, Chen D, Zhong Y, Wang S, Zhong G. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun 2008; 76: 3415-28.
34. Beatty WL. Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J Cell Sci 2006; 119: 350-9.
35. Su H, McClarty G, Dong F, Hatch GM, Pan ZK, Zhong G. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem 2004; 279: 9409-16.
36. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci USA 2008; 105: 9379-84.
37. Jorgensen I, Valdivia RH. Pmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusion. Infect Immun 2008; 76: 3940-50.
38. Zhong G, Fan T, Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med 1999; 189: 1931-8.
39. Zhong G, Liu L, Fan T, Fan P, Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J Exp Med 2000; 191: 1525-34.
40. Mehlitz A, Banhart S, Hess S, Selbach M, Meyer TF. Complex kinase requirements for Chlamydia trachomatis Tarp phosphorylation. FEMS Microbiol Lett 2008; 289: 233-40.
41. Clifton DR, Dooley CA, Grieshaber SS, Carabeo RA, Fields KA, Hackstadt T. Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin. Infect Immun 2005; 73: 3860-8.
42. Belland RJ, Scidmore MA, Crane DD, et al. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci USA 2001; 98: 13984-9.
43. [Nelson DE, Taylor LD, Shannon JG, et al. Phenotypic rescue of Chlamydia trachomatis growth in IFN-gamma treated mouse cells by irradiated Chlamydia muridarum. Cell Microbiol 2007; 9: 2289-98.
44. Wolf K, Betts HJ, Chellas-Gery B, Hower S, Linton CN, Fields KA. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol 2006; 61: 1543-55.
45. Shivshankar P, Lei L, Wang J, Zhong G. Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells. Appl Environ Microbiol 2008; 74: 1243-9.
46. Bannantine JP, Stamm WE, Suchland RJ, Rockey DD. Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect Immun 1998; 66: 6017-21.
47. Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol 1999; 33: 753-65.
48. Bannantine JP, Griffiths RS, Viratyosin W, Brown WJ, Rockey DD. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol 2000; 2: 35-47.
49. Bannantine JP, Rockey DD, Hackstadt T. Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane. Mol Microbiol 1998; 28: 1017-26.
50. Sisko JL, Spaeth K, Kumar Y, Valdivia RH. Multifunctional analysis of Chlamydia-specific genes in a yeast expression system. Mol Microbiol 2006; 60: 51-66.
51. Fields KA, Hackstadt T. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol 2000; 38: 1048-60.
52. Belland RJ, Zhong G, Crane DD, et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 2003; 100: 8478-83.
53. Jia TJ, Liu DW, Luo JH, Zhong GM. [Localization of the hypothetical protein CT249 in the Chlamydia trachomatis inclusion membrane]. Wei Sheng Wu Xue Bao 2007; 47: 645-8.
54. Starnbach MN, Loomis WP, Ovendale P, et al. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. J Immunol 2003; 171: 4742-9.
55. Fling SP, Sutherland RA, Steele LN, et al. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci USA 2001; 98: 1160-5.
56. Chen C, Chen D, Sharma J, et al. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect Immun 2006; 74: 4826-40.
57. Toh H, Miura K, Shirai M, Hattori M. In silico inference of inclusion membrane protein family in obligate intracellular parasites chlamydiae. DNA Res 2003; 10: 9-17.
58. Delevoye C, Nilges M, Dautry-Varsat A, Subtil A. Conservation of the biochemical properties of IncA from Chlamydia trachomatis and Chlamydia caviae: oligomerization of IncA mediates interaction between facing membranes. J Biol Chem 2004; 279: 46896-906.
59. Scidmore MA, Hackstadt T. Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol 2001; 39: 1638-50.
60. Alzhanov DT, Weeks SK, Burnett JR, Rockey DD. Cytokinesis is blocked in mammalian cells transfected with Chlamydia trachomatis gene CT223. BMC Microbiol 2009; 9: 2.
61. Alzhanov D, Barnes J, Hruby DE, Rockey DD. Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA. BMC Microbiol 2004; 4: 24.
62. Luo J, Liu G, Zhong Y, et al. Characterization of hypothetical proteins Cpn0146, 0147, 0284 & 0285 that are predicted to be in the Chlamydia pneumoniae inclusion membrane. BMC Microbiol 2007; 7: 38.
63. Flores R, Luo J, Chen D, et al. Characterization of the hypothetical protein Cpn1027, a newly identified inclusion membrane protein unique to Chlamydia pneumoniae. Microbiology 2007; 153: 777-86.
64. Greene W, Xiao Y, Huang Y, McClarty G, Zhong G. Chlamydiainfected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun 2004; 72: 451-60.
65. Greene W, Zhong G. Inhibition of host cell cytokinesis by Chlamydia trachomatis infection. J Infect 2003; 47: 45-51.
66. Grieshaber SS, Grieshaber NA, Miller N, Hackstadt T. Chlamydia trachomatis causes centrosomal defects resulting in chromosomal segregation abnormalities. Traffic 2006; 7: 940-9.
67. Johnson KA, Tan M, Sutterlin C. Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway. Cell Microbiol 2009; 11: 1064-73.
68. Hackstadt T, Scidmore-Carlson MA, Shaw EI, Fischer ER. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1999; 1: 119-30.
69. Rzomp KA, Moorhead AR, Scidmore MA. The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun 2006; 74: 5362-73.
70. Rzomp KA, Scholtes LD, Briggs BJ, Whittaker GR, Scidmore MA. Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect Immun 2003; 71: 5855-70.
71. Cortes C, Rzomp KA, Tvinnereim A, Scidmore MA, Wizel B. Chlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPases. Infect Immun 2007; 75: 5586-96.
72. Delevoye C, Nilges M, Dehoux P, et al. SNARE protein mimicry by an intracellular bacterium. PLoS Pathog 2008; 4: e1000022.
73. Huang Z, Feng Y, Chen D, et al. Structural basis for activation and inhibition of the secreted Chlamydia Protease CPAF. Cell Host Microbe 2008; 4: 529-42.
74. Dong F, Su H, Huang Y, Zhong Y and Zhong G. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect Immun 2004; 72: 3863-8.
75. Pirbhai M, Dong F, Zhong Y, Pan KZ, Zhong G. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J Biol Chem 2006; 281: 31495-501.
76. Vandahl BB, Stensballe A, Roepstorff P, Christiansen G, Birkelund S. Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell Microbiol 2005; 7: 825-36.
77. Dong F, Flores R, Chen D, et al. Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniaeinfected host cells. Infect Immun 2006; 74: 6479-86.
78. Hobolt-Pedersen AS, Christiansen G, Timmerman E, Gevaert K, Birkelund S. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol Med Microbiol 2009; 57: 46-58.
79. Lad SP, Li J, da Silva Correia J, et al. Cleavage of p65/RelA of the NF-kappaB pathway by Chlamydia. Proc Natl Acad Sci USA 2007; 104: 2933-8.
80. Lad SP, Yang G, Scott DA, et al. Chlamydial CT441 is a PDZ domain-containing tail-specific protease that interferes with the NF-kappaB pathway of immune response. J Bacteriol 2007; 189: 6619-25.
81. Chellas-Gery B, Linton CN, Fields KA. Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Cell Microbiol 2007; 9: 2417-30.
82. Le Negrate G, Krieg A, Faustin B, et al. ChlaDub1 of Chlamydia trachomatis suppresses NF-kappaB activation and inhibits Ikappa Balpha ubiquitination and degradation. Cell Microbiol 2008; 10: 1879-92.
83. Misaghi S, Balsara ZR, Catic A, Spooner E, Ploegh HL, Starnbach MN. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 2006; 61: 142-50.
84. Kumar Y, Cocchiaro J, Valdivia RH. The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 2006; 16: 1646-51.
85. Zhong G. Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol 2009; 17: 467-74.
86. Fan T, Lu H, Hu H, et al. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 1998; 187: 487-96.
87. Geng Y, Shane RB, Berencsi K, et al. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol 2000; 164: 5522-9.
88. Fischer SF, Vier J, Kirschnek S, et al. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 2004; 200: 905-16.
89. Dean D, Powers VC. Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Infect Immun 2001; 69: 2442-7.
90. Rajalingam K, Al-Younes H, Muller A, Meyer TF, Szczepek AJ, Rudel T. Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect Immun 2001; 69: 7880-8.
91. van Zandbergen G, Gieffers J, Kothe H, et al. Chlamydia pneum niae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 2004; 172: 1768-76.
92. Xiao Y, Zhong Y, Greene W, Dong F, Zhong G. Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect Immun 2004; 72: 5470-4.
93. Dong F, Pirbhai M, Xiao Y, Zhong Y, Wu Y, Zhong G. Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect Immun 2005; 73: 1861-4.
94. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99: 77-87.
95. Cheng W, Shivshankar P, Zhong Y, Chen D, Li Z, Zhong G. Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect Immun 2008; 76: 942-51.
96. Xiao Y, Zhong Y, Su H, Zhou Z, Chiao P, Zhong G. NF-kappa B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis. J Immunol 2005; 174: 1701-8.
97. Heinzen RA, Hackstadt T. The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to lowmolecular-weight compounds. Infect Immun 1997; 65: 1088-94.
98. Kumar Y, Valdivia RH. Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 2008; 4: 159-69.
99. Savijoki K, Alvesalo J, Vuorela P, Leinonen M, Kalkkinen N. Proteomic analysis of Chlamydia pneumoniae-infected HL cells reveals extensive degradation of cytoskeletal proteins. FEMS Immunol Med Microbiol 2008; 54: 375-84.
100. Hackstadt T, Scidmore MA, Rockey DD. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgiderived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci USA 1995; 92: 4877-81.
101. Carabeo RA, Mead DJ, Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci USA 2003; 100: 6771-6.
102. Beatty WL. Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63. Infect Immun 2008; 76: 2872-81.
103. Robertson DK, Gu L, Rowe RK, Beatty WL. Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog 2009; 5:e1000664.
104. Heuer D, Lipinski AR, Machuy N, et al. Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature 2009; 457: 731-5.
105. Horn M, Collingro A, Schmitz-Esser S, et al. Illuminating the evolutionary history of chlamydiae. Science 2004; 304: 728-30.
106. Pachikara N, Zhang H, Pan Z, Jin S, Fan H. Productive Chlamydia trachomatis lymphogranuloma venereum 434 infection in cells with augmented or inactivated autophagic activities. FEMS Microbiol Lett 2009; 292: 240-9.
107. Hybiske K, Stephens RS. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci USA 2007; 104: 11430-5.
108. Suchland RJ, Rockey DD, Weeks SK, Alzhanov DT, Stamm WE. Development of secondary inclusions in cells infected by Chlamydia trachomatis. Infect Immun 2005; 73: 3954-62.
109. Sharma J, Zhong Y, Dong F, Piper JM, Wang G, Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 2006; 74: 1490-9.
110. Arnold R, Brandmaier S, Kleine F, et al. Sequence-based prediction of type III secreted proteins. PLoS Pathog 2009; 5: e1000376.
111. Samudrala R, Heffron F, McDermott JE. Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog 2009; 5: e1000375.
112. Fields KA, Fischer ER, Mead DJ and Hackstadt T. Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J Bacteriol 2005; 187: 6466-78.
113. Subtil A, Delevoye C, Balana ME, Tastevin L, Perrinet S and Dautry-Varsat A. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 2005; 56: 1636-47.
114. Subtil A, Parsot C, Dautry-Varsat A. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol 2001; 39: 792-800.
115. Spaeth KE, Chen YS, Valdivia RH. The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex. PLoS Pathog 2009; 5: e1000579.
116. Slepenkin A, de la Maza LM, Peterson EM. Interaction between components of the type III secretion system of Chlamydiaceae. J Bacteriol 2005; 187: 473-9.
117. Kleba B, Stephens RS. Chlamydial effector proteins localized to the host cell cytoplasmic compartment. Infect Immun 2008; 76: 4842-50.
118. Shaw AC, Vandahl BB, Larsen MR, et al. Characterization of a secreted Chlamydia protease. Cell Microbiol 2002; 4: 411-24.
119. Fan P, Dong F, Huang Y, Zhong G. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression. Infect Immun 2002; 70: 345-9.
120. Heuer D, Brinkmann V, Meyer TF, Szczepek AJ. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol 2003; 5: 315-22.
121. Muschiol S, Bailey L, Gylfe A, et al. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 2006; 103: 14566-71.